This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Szucs, T. D Search for Related Content PubMed PubMed Citation Articles by Szucs, T. D Pubmed/NCBI databases Medline Plus Health Information Choosing a Doctor or Health Care Service Heart Failure Social Bookmarking                         What's this?

The growing healthcare burden of CHF

University Hospital, Zurich, Switzerland, thomas.szucs{at}vdi.usz.ch

Despite advances in treatment, congestive heart failure (CHF) remains a major burden on healthcare budgets throughout the western world. Two main factors in the increasing incidence of CHF are the shift in the age distribution of the population and, paradoxically, an improvement in the management of other conditions, such as myocardial infarction. This increases the number of patients surviving acute cardiovascular events who proceed to develop CHF. Certain sub-populations of patients consume most of the healthcare resources devoted to CHF management, with some 90% of resources utilised by patients in NYHA classes III or IV, and hospitalisation accounting for 60 to 75% of overall costs.

Management strategies aimed at reducing both disease severity and the need for hospitalisation are therefore likely to be most effective in reducing the economic burden of CHF on healthcare systems.

Key Words: pharmaco-economics • cardiovascular disease • CHF

References

• Eriksson H. Heart failure: a growing public health problem. J Int Med 1995;237:135-41.[Web of Science][Medline] [Order article via Infotrieve]
• Joint National Committee. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH Publication No. 98-4080, 1997.
• Mosterd A. Heart failure in the population at large; news from the real world. Eur Heart J 1999;20:398-9.[Web of Science][Medline] [Order article via Infotrieve]
• Cleland JGF Heart failure: a medical hydra. Lancet 1998; 352 Suppl 1:1-2.[CrossRef][Medline] [Order article via Infotrieve]
• Cowie MR, MosterdA, Wood DA et al.The epidemiology of heart failure. Eur Heart J 1997;18:208-25.[Free Full Text]
• 2000 heart and stroke statistical update. Dallas: American Heart Association, 1999.
• Rich MW Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 1997; 45:968-74.[Web of Science][Medline] [Order article via Infotrieve]
• Remes J., Reunanen A., Aromaa A., Pyorala K. Incidence of heart failure in eastern Finland: a population-based surveillance study. Eur Heart J 1992;13:588-93.[Abstract/Free Full Text]
• Lamberts H., Brouwer HJ, Mohrs J. Reason for encounter - an episode and process oriented standard output from the Transition Project. Part 1 & 2.Amsterdam: Dept. of General Practice, 1993.
• Van de Lisdonk EH, Van den Bosch Wjhm, Huygen FJA, Lagro-Jansen ALM Diseases in general practice. Utrecht, the Netherlands: Bunge, 1990.
• Royal College of General Practitioners, Office of Population Census and Survey, and Department of Health and Social Security. Morbidity statistics from general practice: fourth national study, 1991-92. London: HMSO, 1995.
• Eriksson H., Svardsudd K., Larsson B. et al. Risk factors for heart failure in the general population.The study of men born in 1913. Eur Heart J 1989;10:647-56.[Abstract/Free Full Text]
• Moser DK Heart failure in women. Crit Care Nurs Clin North Am 1997;9:511-9.[Medline] [Order article via Infotrieve]
• Sytkowski PA, Kannel WB, D'Agostino RB Changes in risk factors and the decline in mortality from cardiovascular disease.The Framingham Heart Study. N Engl J Med 1990;322:1635-41.[Abstract]
• Lenfant C. Report of the Task Force on research in heart failure. Circulation 1994;90:1118-23.[Free Full Text]
• Ho KK, Anderson KM, Kannel WB, Grossman W., Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-15.[Abstract/Free Full Text]
• Cochran A., Wilson BA Current management of AIDS and related opportunistic infections. Medsurg Nurs 1999;8:257-64.[Medline] [Order article via Infotrieve]
• Moreau P. Autologous stem cell transplantation for AL amyloidosis: a standard therapy? Leukemia 1999;13:1929-31.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Coats AJS Is preventive medicine responsible for the increasing prevalence of heart failure? Lancet 1998;352 Suppl 1:39-41.[Medline] [Order article via Infotrieve]
• ClarkAL CoatsAJ New evidence for improved survival in chronic heart failure. Clin Cardiol 1994;17:55-8.[Web of Science][Medline] [Order article via Infotrieve]
• Lip GYH, Gibbs CR, Beevers DG ABC of Heart Failure: aetiology. Br Med J 2000;320:104-7.[Free Full Text]
• Lip GYH, Sarwar S.,Ahmed I. et al. A survey of heart failure in general practice. The West Birmingham Heart Failure Project. Eur J Gen Pract 1997;3: 85-9.[Medline] [Order article via Infotrieve]
• Sharpe N., Doughty R. Epidemiology of heart failure and ventricular dysfunction. Lancet 1998;352 Suppl 1:3-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Erhardt LR, Cline CMJ Organisation of the care of patients with heart failure. Lancet 1998;352 Suppl 1:15-18.
• Cleland JGF Health economic consequences of the pharmacological treatment of heart failure. Eur Heart J 1998;19 Suppl P:P32-P39.[Web of Science][Medline] [Order article via Infotrieve]
• McMurray J., Hart W. The economic impact of heart failure on the UK National Health Service. Eur Heart J 1993;14 Suppl:133.[Web of Science][Medline] [Order article via Infotrieve]
• Ryden-Bergsten T., Andersson F. The health care costs of heart failure in Sweden. J Intern Med 1999;246:275-84.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• McMurray J. et al. Reduced costs with bisoprolol treatment for heart failure: an economic analysis of the second cardiac insufficiency bisoprolol study (CIBIS II). Abstract, European Society of Cardiology, Barcelona,August 1999.

Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 1 suppl, 2-6 (2000)
DOI: 10.3317/jraas.2000.029


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				N. Dib, R. E. Michler, F. D. Pagani, S. Wright, D. J. Kereiakes, R. Lengerich, P. Binkley, D. Buchele, I. Anand, C. Swingen, et al. Safety and Feasibility of Autologous Myoblast Transplantation in Patients With Ischemic Cardiomyopathy: Four-Year Follow-Up Circulation, September 20, 2005; 112(12): 1748 - 1755. [Abstract] [Full Text] [PDF]

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Szucs, T. D Search for Related Content PubMed PubMed Citation Articles by Szucs, T. D Pubmed/NCBI databases Medline Plus Health Information Choosing a Doctor or Health Care Service Heart Failure Social Bookmarking                         What's this?